Ó£»¨ÊÓÆµ

Skip to main content

Table 1 Characteristics of the study participants according to serum uric acid quartiles by gender

From: Gender-specific association between serum uric acid levels and hypertension in East China: a cross-sectional study

Characteristics

Males

Females

Q1

Q2

Q3

Q4

P Value

Q1

Q2

Q3

Q4

P Value

N (participants, %)

3599 (25.0)

3599 (25.0)

3602 (25.0)

3599 (25.0)

Ìý

3170 (25.0)

3164 (25.0)

3173 (25.0)

3169 (25.0)

Ìý

Age, y

44 (35, 54)

42 (34, 51)

40 (33, 49)

38 (32, 47)

&±ô³Ù; 0.0001

39 (33, 46)

38 (32, 47)

39 (32, 48)

39 (32, 50)

0.0197

Uric acid, µ mol/L

314.4 (287.7, 332.7)

372.4 (360.1, 384,0)

420.2 (407.6, 434.0)

489.1 (465.9, 524.2)

&±ô³Ù; 0.0001

221.2 (202.5, 234.0)

263.7 (254.5, 272.5)

299.4 (290.0, 309.7)

353.5 (335.0, 382.5)

&±ô³Ù; 0.0001

BMI, kg/m2

23.7 (21.8, 25.5)

24.4 (22.7, 26.2)

25.1 (23.4, 27.0)

26.1 (24.2, 28.3)

&±ô³Ù; 0.0001

21.1 (19.7, 22.8)

21.5 (20.0, 23.3)

21.9 (20.4, 23.9)

23.1 (21.1, 25.4)

&±ô³Ù; 0.0001

Pulse, beats/min

78 (70, 86)

78 (71, 86)

78 (71, 87)

79 (72, 87)

&±ô³Ù; 0.0001

83 (76, 91)

83 (75, 91)

83 (75, 92)

83 (75, 91)

0.6124

SBP, mm Hg

124 (115, 135)

124 (116, 135)

125 (116, 135)

127 (118, 137)

&±ô³Ù; 0.0001

115 (107, 125)

115 (107, 125)

116 (107, 126)

119 (109, 130)

&±ô³Ù; 0.0001

DBP, mm Hg

76 (70, 84)

77 (71, 84)

78 (71, 86)

79 (73, 87)

&±ô³Ù; 0.0001

70 (65, 77)

71 (65, 77)

71 (65, 78)

73 (66, 80)

&±ô³Ù; 0.0001

FBG, mmol/L

5.2 (4.9, 5.6)

5.1 (4.8, 5.5)

5.2 (4.9, 5.5)

5.2 (4.9, 5.5)

&±ô³Ù; 0.0001

4.9 (4.7, 5.2)

4.9 (4.7, 5.2)

5.0 (4.7, 5.3)

5.0 (4.7, 5.4)

&±ô³Ù; 0.0001

Creatinine, µ mol/L

70.2 (64.5, 76.2)

72.7 (67.1, 78.6)

73.7 (67.9, 79.9)

75.6 (69.3, 82.3)

&±ô³Ù; 0.0001

49.9 (45.9, 54.1)

51.9 (47.7, 56.4)

52.6 (48.3, 57.3)

54.5 (49.4, 59.8)

&±ô³Ù; 0.0001

eGFR, mL/min/1.73m2

137.0

(123.7, 152.3)

132.9

(120.4, 146.4)

131.7

(118.5, 145.6)

128.7

(115.7, 143.1)

&±ô³Ù; 0.0001

154.4

(139.2, 171.0)

147.8

(133.3, 164.2)

144.6

(130.1, 161.2)

138.8

(123.2, 156.7)

&±ô³Ù; 0.0001

TG, mmol/L

1.2 (0.9, 1.7)

1.4 (1.0, 1.9)

1.6 (1.1, 2.2)

1.9 (1.3, 2.7)

&±ô³Ù; 0.0001

0.8 (06, 1.1)

0.9 (0.7, 1.2)

1.0 (0.7, 1.3)

1.2 (0.8, 1.7)

&±ô³Ù; 0.0001

TC, mmol/L

4.8 (4.3, 5.4)

4.9 (4.4, 5.5)

5.0 (4.4, 5.5)

5.1 (4.6, 5.7)

&±ô³Ù; 0.0001

4.7 (4.2, 5.2)

4.7 (4.2, 5.3)

4.8 (4.3, 5.4)

5.0 (4.4, 5.6)

&±ô³Ù; 0.0001

HDL, mmol/L

1.2 (1.1, 1.4)

1.2 (1.0, 1.3)

1.11(1.0, 1.3)

1.1 (1.0, 1.2)

&±ô³Ù; 0.0001

1.5 (1.3, 1.8)

1.5 (1.3, 1.7)

1.4 (1.2, 1.7)

1.4 (1.2, 1.6)

&±ô³Ù; 0.0001

LDL, mmol/L

2.9 (2.4, 3.4)

3.0 (2.5, 3.5)

3.1 (2.6, 3.6)

3.2 (2.6, 3.7)

&±ô³Ù; 0.0001

2.6 (2.1, 3.1)

2.7 (2.2, 3.2)

2.8 (2.3, 3.3)

2.9 (2.4, 3.5)

&±ô³Ù; 0.0001

Diabetes, N (%)

ÌýÌýÌýÌý

&±ô³Ù; 0.0001

ÌýÌýÌýÌý

0.0320

Yes

203 (5.6)

103 (2.9)

83 (2.3)

53 (1.5)

Ìý

22 (0.7)

23 (0.7)

14 (0.4)

34 (1.1)

Ìý

No

3396 (94.4)

3496 (97.1)

3519 (97.7)

3546 (98.5)

Ìý

3148 (99.3)

3141 (99.3)

3159 (99.6)

3135 (98.9)

Ìý

Hypertension, N (%)

ÌýÌýÌýÌý

&±ô³Ù; 0.0001

ÌýÌýÌýÌý

&±ô³Ù; 0.0001

Yes

742 (20.6)

761 (21.1)

791 (22.0)

939 (26.1)

Ìý

248 (7.8)

291 (9.2)

307 (9.7)

456 (14.4)

Ìý

No

2857 (79.4)

2838 (78.9)

2811 (78.0)

2660 (73.9)

Ìý

2922 (92.2)

2873 (90.8)

2866 (90.3)

2713 (85.6)

Ìý

High SBP, N (%)

ÌýÌýÌýÌý

&±ô³Ù; 0.0001

ÌýÌýÌýÌý

&±ô³Ù; 0.0001

Yes

554 (15.4)

552 (15.3)

569 (15.8)

682 (19.0)

Ìý

196 (6.2)

226 (7.1)

247 (7.8)

371 (11.7)

Ìý

No

3045 (84.6)

3047 (84.7)

3033 (84.2)

2917 (81.1)

Ìý

2974 (93.8)

2938 (92.9)

2926 (92.2)

2798 (88.3)

Ìý

High DBP, N (%)

ÌýÌýÌýÌý

&±ô³Ù; 0.0001

ÌýÌýÌýÌý

&±ô³Ù; 0.0001

Yes

379 (10.5)

413 (11.5)

493 (13.7)

575 (16.0)

Ìý

111 (3.5)

112 (3.5)

123 (3.9)

187 (5.9)

Ìý

No

3220 (89.5)

3186 (88.5)

3109 (86.3)

3024 (84.0)

Ìý

3059 (96.5)

3052 (96.5)

3050 (96.1)

2982 (94.1)

Ìý
  1. Cut-points: Serum uric acid quartiles (Q1–Q4) in men (Q1: ≤ 346.70; Q2: 346.70–395.30; Q3: 395.30–448.70; and Q4: ≥ 448.70 µ mol/L). In women (Q1: ≤ 244.50; Q2: 244.50–281.10; Q3: 281.10–320.80; and Q4: ≥ 320.80 µ mol/L). BMI„ body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; eGFR, estimated glomerular filtration rate; TG, triglycerides; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein. *Continuous variables are expressed as median (interquartile range). Categorical variables are expressed as frequency (percent)